biospecimen__admin__batch_number	275.62.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	3C7865BA-B6B6-40DF-81E8-032D9B3BD1A6
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A4ND-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A4ND-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A4ND-01A
biospecimen__bio__biospecimen_barcode_bottom	0128925197
biospecimen__bio__day_of_creation	01
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-DD-A4ND.64D878AE-DEEA-4C56-854C-3774038E2914.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A266
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.08
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2012
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A4ND
biospecimen__shared__patient_id	A4ND
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	CD554BC6-2F76-432E-8C07-522E1EBD9581
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.9
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12
clinical__chol_lihc_shared__prothrombin_time_result_value	8.8
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	56
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A4ND-F43021
clinical__clin_shared__bcr_followup_uuid	82C537E3-5160-464C-9446-34B869BA0CFA
clinical__clin_shared__cancer_first_degree_relative	3
clinical__clin_shared__day_of_form_completion	21
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Complete Response
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2007
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	15
clinical__nte__new_tumor_event_additional_surgery_procedure	YES
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__nte__residual_disease_post_new_tumor_event_margin_status	R0
clinical__rx__bcr_drug_barcode	TCGA-DD-A4ND-D43026
clinical__rx__bcr_drug_uuid	8E76F1B7-7EFB-4AF9-A238-BF6BDDD6587F
clinical__rx__days_to_drug_therapy_end	218
clinical__rx__days_to_drug_therapy_start	20
clinical__rx__drug_name	Adriamycin/Cytoxan
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	Yes
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	b3d02a68-fde3-42cd-8ca2-7e3565f85632
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A4ND-01A-11R-A266-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	d4d40fcf-1aab-460c-afdb-7cadbb11c93b,bf57b8cf-2a94-4c79-a2b1-475c105f86cd,7e022eab-16b0-4bfe-b009-8c61eb1b8533
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.92
gdc__analytes__analyte_id	db86e8d8-7a31-4a55-8791-4f13842dd216
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	c0bf9278-9cbb-4361-b4d8-ab172b67e276
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-30T18:43:18.368050-05:00,2016-05-30T18:43:18.751420-05:00,2016-05-30T18:43:18.575348-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	558fa8f5-53b3-5466-b48f-1b65cc077fdf
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1951
gdc__diagnoses__age_at_diagnosis	20782
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-20782.0
gdc__diagnoses__days_to_last_follow_up	2746.0
gdc__diagnoses__diagnosis_id	b5f79a87-9e12-5bcc-9bcb-77807a7df2dd
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	33.91251333638165
gdc__exposures__exposure_id	8459c1fd-25fb-5841-aa4a-9a79cf0c7adc
gdc__exposures__height	162.0
gdc__exposures__weight	89.0
gdc__file_id	2717e519-f426-42ac-9b9a-293365453975,8490e16f-975f-4618-a561-e0621f3bc75b,b060f8c5-8301-41b0-a544-fe4dcb4910bb
gdc__file_name	73756e81-79a2-4bff-96e7-99f038306b3e.htseq.counts.gz,73756e81-79a2-4bff-96e7-99f038306b3e.FPKM.txt.gz,73756e81-79a2-4bff-96e7-99f038306b3e.FPKM-UQ.txt.gz
gdc__file_size	251771,519956,522553
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	a546f25a9d2149469e552cd372d0f5b8,3892a3cc47c10800c845ad882bf8e15c,f29d4c38c70111b414af228700d9c6d6
gdc__portions__is_ffpe	false
gdc__portions__portion_id	5483aca4-42d6-4ba2-ba01-bd81eb0f238a
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	2088
gdc__samples__initial_weight	140.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	64D878AE-DEEA-4C56-854C-3774038E2914
gdc__samples__sample_id	4282039e-396b-44d8-b4ec-ac14c46ddef6
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	75.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	b610f380-cdab-4d97-9d2b-fc8e4e78d841
gdc__submitter_id	73756e81-79a2-4bff-96e7-99f038306b3e_count,73756e81-79a2-4bff-96e7-99f038306b3e_fpkm,73756e81-79a2-4bff-96e7-99f038306b3e_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	3e1ab4b2-f8cf-55d7-bd33-9f7b67de1d18
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:09:56.553+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/b3d02a68-fde3-42cd-8ca2-7e3565f85632-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/b3d02a68-fde3-42cd-8ca2-7e3565f85632-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5144361
manually_curated__local_md5	1ce75ace4890a7122e81bf353c3ea951
manually_curated__opengdc_download_date	2018-10-15T16:26:05.000160+02:00
manually_curated__opengdc_file_md5	afd20e72ec36e1fb7d497d8863590f8d
manually_curated__opengdc_file_size	1693791
manually_curated__opengdc_id	b3d02a68-fde3-42cd-8ca2-7e3565f85632-geq
manually_curated__origin_file_size	5144361
manually_curated__origin_last_modified_date	Mon Oct 15 16:37:00 CEST 2018
manually_curated__origin_md5	1ce75ace4890a7122e81bf353c3ea951
manually_curated__tissue_status	tumoral
num	60483
